HLB Pharmaceutical (Korea) Probability of Future Stock Price Finishing Over 20,265
| 047920 Stock | KRW 21,050 400.00 1.94% |
HLB |
HLB Pharmaceutical Target Price Odds to finish over 20,265
The tendency of HLB Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 21,050 | 90 days | 21,050 | about 68.18 |
Based on a normal probability distribution, the odds of HLB Pharmaceutical to move above the current price in 90 days from now is about 68.18 (This HLB Pharmaceutical Co probability density function shows the probability of HLB Stock to fall within a particular range of prices over 90 days) .
Assuming the 90 days trading horizon HLB Pharmaceutical Co has a beta of -0.18. This suggests as returns on the benchmark increase, returns on holding HLB Pharmaceutical are expected to decrease at a much lower rate. During a bear market, however, HLB Pharmaceutical Co is likely to outperform the market. Additionally HLB Pharmaceutical Co has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. HLB Pharmaceutical Price Density |
| Price |
Predictive Modules for HLB Pharmaceutical
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as HLB Pharmaceutical. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.HLB Pharmaceutical Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. HLB Pharmaceutical is not an exception. The market had few large corrections towards the HLB Pharmaceutical's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold HLB Pharmaceutical Co, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of HLB Pharmaceutical within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.3 | |
β | Beta against Dow Jones | -0.18 | |
σ | Overall volatility | 3,322 | |
Ir | Information ratio | -0.09 |
HLB Pharmaceutical Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of HLB Pharmaceutical for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for HLB Pharmaceutical can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| HLB Pharmaceutical generated a negative expected return over the last 90 days | |
| HLB Pharmaceutical has high historical volatility and very poor performance | |
| The company reported the revenue of 62.85 B. Net Loss for the year was (13.23 B) with profit before overhead, payroll, taxes, and interest of 18.04 B. | |
| HLB Pharmaceutical Co has accumulated about 6.64 B in cash with (1.32 B) of positive cash flow from operations. | |
| Roughly 26.0% of the company shares are owned by insiders or employees |
HLB Pharmaceutical Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of HLB Stock often depends not only on the future outlook of the current and potential HLB Pharmaceutical's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. HLB Pharmaceutical's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 26.1 M | |
| Cash And Short Term Investments | 25.5 B |
HLB Pharmaceutical Technical Analysis
HLB Pharmaceutical's future price can be derived by breaking down and analyzing its technical indicators over time. HLB Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of HLB Pharmaceutical Co. In general, you should focus on analyzing HLB Stock price patterns and their correlations with different microeconomic environments and drivers.
HLB Pharmaceutical Predictive Forecast Models
HLB Pharmaceutical's time-series forecasting models is one of many HLB Pharmaceutical's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary HLB Pharmaceutical's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about HLB Pharmaceutical
Checking the ongoing alerts about HLB Pharmaceutical for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for HLB Pharmaceutical help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| HLB Pharmaceutical generated a negative expected return over the last 90 days | |
| HLB Pharmaceutical has high historical volatility and very poor performance | |
| The company reported the revenue of 62.85 B. Net Loss for the year was (13.23 B) with profit before overhead, payroll, taxes, and interest of 18.04 B. | |
| HLB Pharmaceutical Co has accumulated about 6.64 B in cash with (1.32 B) of positive cash flow from operations. | |
| Roughly 26.0% of the company shares are owned by insiders or employees |
Other Information on Investing in HLB Stock
HLB Pharmaceutical financial ratios help investors to determine whether HLB Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in HLB with respect to the benefits of owning HLB Pharmaceutical security.